
Germany to boost the bioeconomy
One month before the Summit, the Bioeconomy Council warned that Germany could lose its leading role in the bioeconomy. According to a country study...

AML: Sorafenib boosts graft-versus-leukemia activity
"Originally, sorafenib was only given to patients to slow the progression of the disease. We then found that the cancer disappears in patients...

Novartis in US$170m licence deal with Spark Therapeutics
The Swiss pharma major paid US$105m upfront for the commercialisation rights for the first-in-class gene therapy Luxturna outside the US market....

Poor investigator brochures: Resarchers call for standardisation
Poor animal study design and reporting thwarts the ethical review of proposed human drug trials, according to the study led by researchers under...

German biotech sector growing
Key figures for the sector rose sharply in 2017, the BIOCOM report "The German biotech industry 2018" biotechnologie.de says, which has...

New Screening method for Antibiotic Discovery Pipeline
An alarming number of bacteria are becoming resistant to front-line therapies. However, only yet few new antibiotics have reached the market in the...

Convert Pharmaceuticals SA closes €13.6m Series A round
The proceeds will be used to prepare and conduct Phase I clinical studies with Convert's nitroaromatic lead anti-cancer drug CP-506, which may bring...